ANSTO Synroc® Treatment Facility
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
Showing 401 - 420 of 1223 results
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
The nuclear medicine community has welcomed the Australian Government’s decision to provide $30 million in funding to ANSTO for the design of a new nuclear medicine manufacturing facility.
ANSTO is part of a contingent showcasing Australian science at the Australian Pavilion at the World Expo Osaka in October.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
ANSTO is coordinating and facilitating a new cycle of Australian project proposals for the Regional Cooperative Agreement (RCA).
Insights into the crystallisation process of twin crystals important for drug production.
The new trilateral security partnership between Australia, the UK and the US (AUKUS) is a historically significant development for nuclear science and technology in Australia.
The Australian Government recently signed a landmark emissions reduction technology deal with Great Britain, which includes nuclear energy and clean hydrogen among the six key low emission technologies the two countries hope to advance.
ANSTO-nandin innovation hub win global hackathon challenge from NASA with COVID19 solution.
Pioneering work on materials for energy production, such as lithium ion batteries, has made ANSTO a centre of specialist capabilities and expertise.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
Imperial College London researchers tapped into ancient geological data locked within precariously balanced rocks using a new technique to boost the precision of hazard estimates for large earthquakes.
Research undertaken by Flinders University, the University of Cincinnati (US), Guangzhou University (China) and ANSTO has evaluated a new process to encapsulate fish oil in nanoparticles